Physician Assistant · Cut Off, LA
NPI
1073660676
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
144 W 134th St
Cut Off, LA, 70345
Phone (985) 632-8367
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$113K
1,684 prescriptions
Company payments, 2025
$686
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Brett J Duplantis prescribed most often to Medicare patients was Fluticasone Propionate, with 108 prescriptions and refills. In total Brett J Duplantis wrote 1,684 Medicare prescriptions that cost $113K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fluticasone Propionate Generic | 108 | 125 | 81 | $1,315 |
| Tramadol Hcl Generic | 105 | 105 | 24 | $91.06 |
| Metformin Hcl Generic | 60 | 146 | 16 | $156 |
| Alprazolam Generic | 55 | 55 | Under 11 | $95.25 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 47 | 54 | 11 | $1,355 |
| Diazepam Generic | 42 | 42 | Under 11 | $125 |
| Mupirocin Generic | 35 | 35 | 19 | $276 |
| Baclofen Generic | 34 | 36 | Under 11 | $221 |
| Atorvastatin Calcium Generic | 33 | 53 | Under 11 | $171 |
| Omeprazole Generic | 31 | 59 | Under 11 | $429 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 29 | $333 |
| Quetiapine Fumarate Generic | 29 | 35 | Under 11 | $465 |
| Mounjaro Tirzepatide | 27 | 27 | Under 11 | $28K |
| Levothyroxine Sodium Generic | 27 | 69 | Under 11 | $233 |
| Ondansetron Odt Ondansetron | 26 | 26 | Under 11 | $163 |
Brand drugs: 144 claims; generic drugs: 1,526 claims; opioid claims: 145.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brett J Duplantis $686 ($686 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $170.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $153 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $64.96 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $50.18 |
| Axsome Therapeutics, Inc. AXSM | 2 | $43.35 |
| Astellas Pharma US Inc 4503.T | 2 | $33.94 |
| Exact Sciences Corporation EXAS | 2 | $33.7 |
| Novo Nordisk Inc NVO | 2 | $30.61 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $19.74 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $18.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.